Permanently Discontinued

APO-IRBESARTAN/HCTZ

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-IRBESARTAN/HCTZ discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-IRBESARTAN/HCTZ 12.5MG 150MG has been permanently discontinued (last updated July 17, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-IRBESARTAN/HCTZ not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength12.5MG 150MG

Last updated2018-07-17

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02387646

Strength

12.5MG 150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

HYDROCHLOROTHIAZIDE IRBESARTAN

Tier

Unrated

Last Updated

2018-07-17

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-IRBESARTAN/HCTZ has 2 shortage/discontinuation reports on file — this is one of them.

2018-02-23

Permanently Discontinued

Business reasons

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244